Contact: Katy Jones
University of North Carolina Health Care
Caption: This technology is based on a gene signature known as "PAM50" originally discovered at UNC Lineberger Comprehensive Cancer Center by Chuck Perou, Ph.D., professor of genetics and pathology and UNC Lineberger member.
Credit: UNC Lineberger Comprehensive Cancer Center
Usage Restrictions: None
Related news release: UNC Lineberger discovery goes from the lab to the patient with FDA approval